Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2024

Open Access 01-12-2024 | Respiratory Microbiota | Research

Gut microbiota and inflammatory factor characteristics in major depressive disorder patients with anorexia

Authors: Fengtao Guo, Lin Jing, Yunfan Xu, Kun Zhang, Ying Li, Ning Sun, Penghong Liu, Huanhu Zhang

Published in: BMC Psychiatry | Issue 1/2024

Login to get access

Abstract

Background

This study aimed to explore the gut microbiota and inflammatory factor characteristics in major depressive disorder (MDD) patients with anorexia and to analyze the correlation between gut microbiota and inflammatory factors, anorexia, and HAMD scores.

Methods

46 MDD patients and 46 healthy controls (HC) were included in the study. The 46 MDD patients were divided into two groups according to whether they had anorexia:20 MDD without anorexia (MDA0 group) and 26 MDD with anorexia (MDA1 group). We used the Hamilton Depression Scale-24 (HAMD-24) to evaluate the depression status of all participants and 16 S ribosomal RNA (16 S rRNA)sequencing to evaluate the composition of the gut microbiota. Inflammatory factors in peripheral blood such as C-reactive protein (CRP) were detected using enzyme-linked immunosorbent assay (ELISA). Spearman’s correlation analysis was used to evaluate the correlation between gut microbiota and inflammatory factors, HAMD scores, and anorexia.

Results

1). CRP was significantly higher in the MDA0, MDA1, than HC. 2). An analysis of α-diversity shows: the Simpson and Pielou indices of the HC group are higher than the MDA1 group (P < 0.05). 3). The β-diversity analysis shows differences in the composition of microbial communities between the MDA0, MDA1, and HC group. 4). A correlation analysis showed that Blautia positively correlated with anorexia, HAMD scores, and CRP level, whereas Faecalibacterium, Bacteroides, Roseburia, and Parabacteroides negatively correlated with anorexia, HAMD scores, and CRP level. 5). The receiver operating characteristic (ROC) curve was drawn using the differential bacterial genera between MDD patients with or without anorexia as biomarkers to identify whether MDD patients were accompanied with anorexia, and its area under curve (AUC) was 0.85. The ROC curve was drawn using the differential bacterial genera between MDD patients with anorexia and healthy controls as biomarkers to diagnose MDD patients with anorexia, with its AUC was 0.97.

Conclusion

This study suggested that MDD patients with anorexia had a distinct gut microbiota compared to healthy individuals, with higher level of CRP. Blautia was more abundant in MDD patients with anorexia and positively correlated with CRP, HAMD scores, and anorexia. The gut microbiota might have influenced MDD and anorexia through the inflammatory factor CRP.
Literature
1.
Peng R, Wang Y, Huang Y, Liu Z, Xu X, Ma Y, Wang L, Zhang M, Yan Y, Wang B, et al. The association of depressive symptoms with disability among adults in China. J Affect Disord. 2022;296:189–97.PubMedCrossRef
2.
Cai H, Jin Y, Liu S, Zhang Q, Zhang L, Cheung T, Balbuena L, Xiang YT. Prevalence of suicidal ideation and planning in patients with major depressive disorder: a meta-analysis of observation studies. J Affect Disord. 2021;293:148–58.PubMedCrossRef
3.
Friedrich MJ. Depression is the leading cause of disability around the World. JAMA. 2017;317(15):1517.PubMed
4.
5.
Udo T, Grilo CM. Psychiatric and medical correlates of DSM-5 eating disorders in a nationally representative sample of adults in the United States. Int J Eat Disord. 2019;52(1):42–50.PubMedCrossRef
6.
Guinhut M, Melchior JC, Godart N, Hanachi M. Extremely severe anorexia nervosa: Hospital course of 354 adult patients in a clinical nutrition-eating disorders-unit. Clin Nutr. 2021;40(4):1954–65.PubMedCrossRef
7.
Keski-Rahkonen A, Mustelin L. Epidemiology of eating disorders in Europe: prevalence, incidence, comorbidity, course, consequences, and risk factors. Curr Opin Psychiatry. 2016;29(6):340–5.PubMedCrossRef
8.
Salvatore P, Baldessarini RJ, Khalsa HK, Tohen M. Prodromal features in first-psychotic episodes of major affective and schizoaffective disorders. J Affect Disord. 2021;295:1251–8.PubMedCrossRef
9.
Simmons WK, Burrows K, Avery JA, Kerr KL, Taylor A, Bodurka J, Potter W, Teague TK, Drevets WC. Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states. Mol Psychiatry. 2020;25(7):1457–68.PubMedCrossRef
10.
Ulfvebrand S, Birgegård A, Norring C, Högdahl L, von Hausswolff-Juhlin Y. Psychiatric comorbidity in women and men with eating disorders results from a large clinical database. Psychiatry Res. 2015;230(2):294–9.PubMedCrossRef
11.
Riquin E, Raynal A, Mattar L, Lalanne C, Hirot F, Huas C, Duclos J, Berthoz S, group, Godart E. N: Is the Severity of the Clinical Expression of Anorexia Nervosa Influenced by an Anxiety, Depressive, or Obsessive-Compulsive Comorbidity Over a Lifetime? Front Psychiatry 2021, 12:658416.
12.
Cassioli E, Rossi E, Martelli M, Arganini F, Giuranno G, Siviglia S, Tarchi L, Faldi M, Castellini G, Ricca V. Longitudinal coupling between eating disorder psychopathology and depression in patients with Anorexia Nervosa and Bulimia Nervosa treated with enhanced cognitive behavior therapy: a one-year Follow-Up study. Brain Sci 2023, 13(4).
13.
Meule A, Kolar DR, Gartner T, Osen B, Rauh E, Naab S, Voderholzer U. Depressive symptoms and weight change in inpatients with anorexia nervosa: a cross-lagged panel model. J Psychosom Res. 2023;172:111391.PubMedCrossRef
14.
Patil CR, Suryakant Gawli C, Bhatt S. Targeting inflammatory pathways for treatment of the major depressive disorder. Drug Discov Today. 2023;28(9):103697.PubMedCrossRef
15.
Kasarello K, Cudnoch-Jedrzejewska A, Czarzasta K. Communication of gut microbiota and brain via immune and neuroendocrine signaling. Front Microbiol. 2023;14:1118529.PubMedPubMedCentralCrossRef
16.
Bai S, Xie J, Bai H, Tian T, Zou T, Chen JJ. Gut microbiota-derived inflammation-related serum metabolites as potential biomarkers for major depressive disorder. J Inflamm Res. 2021;14:3755–66.PubMedPubMedCentralCrossRef
17.
Liu Y, Wang H, Gui S, Zeng B, Pu J, Zheng P, Zeng L, Luo Y, Wu Y, Zhou C, et al. Proteomics analysis of the gut-brain axis in a gut microbiota-dysbiosis model of depression. Transl Psychiatry. 2021;11(1):568.PubMedPubMedCentralCrossRef
18.
Liu L, Wang H, Zhang H, Chen X, Zhang Y, Wu J, Zhao L, Wang D, Pu J, Ji P, et al. Toward a deeper understanding of gut microbiome in Depression: the Promise of Clinical Applicability. Adv Sci (Weinh). 2022;9(35):e2203707.PubMedCrossRef
19.
Zhou M, Fan Y, Xu L, Yu Z, Wang S, Xu H, Zhang J, Zhang L, Liu W, Wu L, et al. Microbiome and tryptophan metabolomics analysis in adolescent depression: roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice. Microbiome. 2023;11(1):145.PubMedPubMedCentralCrossRef
20.
Zhang Y, Zhang J, Wu J, Zhu Q, Chen C, Li Y. Implications of gut microbiota dysbiosis and fecal metabolite changes in psychologically stressed mice. Front Microbiol. 2023;14:1124454.PubMedPubMedCentralCrossRef
21.
Varesi A, Campagnoli LIM, Chirumbolo S, Candiano B, Carrara A, Ricevuti G, Esposito C, Pascale A. The brain-gut-microbiota interplay in depression: a key to design innovative therapeutic approaches. Pharmacol Res. 2023;192:106799.PubMedCrossRef
22.
Radjabzadeh D, Bosch JA, Uitterlinden AG, Zwinderman AH, Ikram MA, van Meurs JBJ, Luik AI, Nieuwdorp M, Lok A, van Duijn CM, et al. Gut microbiome-wide association study of depressive symptoms. Nat Commun. 2022;13(1):7128.PubMedPubMedCentralCrossRef
23.
Tan Y, Zhou L, Huang J, Chen X, Wu Y, Song X, Wang J, Hu H, Yang Q. Vitamin B12, Folate, Homocysteine, Inflammatory mediators (Interleukin-6, Tumor Necrosis factor-alpha and C-Reactive protein) levels in adolescents with anxiety or depressive symptoms. Neuropsychiatr Dis Treat. 2023;19:785–800.PubMedPubMedCentralCrossRef
24.
Chamberlain SR, Cavanagh J, de Boer P, Mondelli V, Jones DNC, Drevets WC, Cowen PJ, Harrison NA, Pointon L, Pariante CM, et al. Treatment-resistant depression and peripheral C-reactive protein. Br J Psychiatry. 2019;214(1):11–9.PubMedPubMedCentralCrossRef
25.
Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22–34.PubMedPubMedCentralCrossRef
26.
Paulsen O, Laird B, Aass N, Lea T, Fayers P, Kaasa S, Klepstad P. The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer. PLoS ONE. 2017;12(5):e0177620.PubMedPubMedCentralCrossRef
27.
Goodrose-Flores C, Bonn S, Klasson C, Helde Frankling M, Trolle Lagerros Y, Bjorkhem-Bergman L. Appetite in Palliative Cancer patients and its association with albumin, CRP and quality of life in men and women-cross-sectional data from the Palliative D-Study. Life (Basel) 2022, 12(5).
28.
Karlovic D, Serretti A, Vrkic N, Martinac M, Marcinko D. Serum concentrations of CRP, IL-6, TNF-alpha and cortisol in major depressive disorder with melancholic or atypical features. Psychiatry Res. 2012;198(1):74–80.PubMedCrossRef
29.
Dunjic-Kostic B, Ivkovic M, Radonjic NV, Petronijevic ND, Pantovic M, Damjanovic A, Poznanovic ST, Jovanovic A, Nikolic T, Jasovic-Gasic M. Melancholic and atypical major depression–connection between cytokines, psychopathology and treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2013;43:1–6.PubMedCrossRef
30.
Liu P, Gao M, Liu Z, Zhang Y, Tu H, Lei L, Wu P, Zhang A, Yang C, Li G, et al. Gut Microbiome Composition linked to inflammatory factors and cognitive functions in First-Episode, drug-naive major depressive disorder patients. Front Neurosci. 2021;15:800764.PubMedCrossRef
31.
Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, Wang W, Tang W, Tan Z, Shi J, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186–94.PubMedCrossRef
32.
Naseribafrouei A, Hestad K, Avershina E, Sekelja M, Linlokken A, Wilson R, Rudi K. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil. 2014;26(8):1155–62.PubMedCrossRef
33.
Kelly JR, Borre Y, C OB, Patterson E, El Aidy S, Deane J, Kennedy PJ, Beers S, Scott K, Moloney G, et al. Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res. 2016;82:109–18.PubMedCrossRef
34.
Breton J, Tirelle P, Hasanat S, Pernot A, L’Huillier C, do Rego JC, Dechelotte P, Coeffier M, Bindels LB, Ribet D. Gut microbiota alteration in a mouse model of Anorexia Nervosa. Clin Nutr. 2021;40(1):181–9.PubMedCrossRef
35.
Cox NJ, Bowyer RCE, Ni Lochlainn M, Wells PM, Roberts HC, Steves CJ. The composition of the gut microbiome differs among community dwelling older people with good and poor appetite. J Cachexia Sarcopenia Muscle. 2021;12(2):368–77.PubMedPubMedCentralCrossRef
36.
Jia W, Peng J, Zhang Y, Zhu J, Qiang X, Zhang R, Shi L. Amelioration impact of gut-brain communication on obesity control by regulating gut microbiota composition through the ingestion of animal-plant-derived peptides and dietary fiber: can food reward effect as a hidden regulator? Crit Rev Food Sci Nutr 2023:1–15.
37.
Han H, Yi B, Zhong R, Wang M, Zhang S, Ma J, Yin Y, Yin J, Chen L, Zhang H. From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators. Microbiome. 2021;9(1):162.PubMedPubMedCentralCrossRef
38.
Fujio-Vejar S, Vasquez Y, Morales P, Magne F, Vera-Wolf P, Ugalde JA, Navarrete P, Gotteland M. The gut microbiota of healthy Chilean subjects reveals a high abundance of the Phylum Verrucomicrobia. Front Microbiol. 2017;8:1221.PubMedPubMedCentralCrossRef
39.
Li M, Su J, Wu J, Zhao D, Huang M, Lu Y, Zheng J, Li H. The Prebiotic Activity of a Novel Polysaccharide Extracted from Huangshui by Fecal Fermentation In Vitro. Foods 2023, 12(24).
40.
Wei C, Yao L, Zhang L, Zhang Y, Luo Q, Qiu S, Zeng X, Chen S, Ye X. In Vitro Digestion and Fecal Fermentation of Peach Gum Polysaccharides with Different Molecular Weights and Their Impacts on Gut Microbiota. Foods 2022, 11(24).
41.
Mirzaei R, Bouzari B, Hosseini-Fard SR, Mazaheri M, Ahmadyousefi Y, Abdi M, Jalalifar S, Karimitabar Z, Teimoori A, Keyvani H, et al. Role of microbiota-derived short-chain fatty acids in nervous system disorders. Biomed Pharmacother. 2021;139:111661.PubMedCrossRef
42.
Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in Gut-Brain communication. Front Endocrinol (Lausanne). 2020;11:25.CrossRef
43.
You H, Tan Y, Yu D, Qiu S, Bai Y, He J, Cao H, Che Q, Guo J, Su Z. The therapeutic effect of SCFA-Mediated regulation of the intestinal environment on obesity. Front Nutr. 2022;9:886902.PubMedPubMedCentralCrossRef
44.
Joo MK, Ma X, Yoo JW, Shin YJ, Kim HJ, Kim DH. Patient-derived Enterococcus mundtii and its capsular polysaccharides cause depression through the downregulation of NF-kappaB-involved serotonin and BDNF expression. Microbes Infect. 2023;25(6):105116.PubMedCrossRef
45.
Li J, Wang J, Wang M, Zheng L, Cen Q, Wang F, Zhu L, Pang R, Zhang A. Bifidobacterium: a probiotic for the prevention and treatment of depression. Front Microbiol. 2023;14:1174800.PubMedPubMedCentralCrossRef
46.
Liu X, Mao B, Gu J, Wu J, Cui S, Wang G, Zhao J, Zhang H, Chen W. Blautia-a new functional genus with potential probiotic properties? Gut Microbes. 2021;13(1):1–21.PubMedCrossRef
47.
Choy CT, Chan UK, Siu PLK, Zhou J, Wong CH, Lee YW, Chan HW, Tsui JCC, Loo SKF, Tsui SKW. A Novel E3 Probiotics Formula Restored Gut Dysbiosis and Remodelled Gut Microbial Network and Microbiome Dysbiosis Index (MDI) in Southern Chinese Adult Psoriasis Patients. Int J Mol Sci 2023, 24(7).
48.
Nishino K, Nishida A, Inoue R, Kawada Y, Ohno M, Sakai S, Inatomi O, Bamba S, Sugimoto M, Kawahara M, et al. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease. J Gastroenterol. 2018;53(1):95–106.PubMedCrossRef
49.
Chung YE, Chen HC, Chou HL, Chen IM, Lee MS, Chuang LC, Liu YW, Lu ML, Chen CH, Wu CS, et al. Exploration of microbiota targets for major depressive disorder and mood related traits. J Psychiatr Res. 2019;111:74–82.PubMedCrossRef
50.
Young SL, Simon MA, Baird MA, Tannock GW, Bibiloni R, Spencely K, Lane JM, Fitzharris P, Crane J, Town I, et al. Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol. 2004;11(4):686–90.PubMedPubMedCentral
51.
Zhang Y, Zhang R, Liu P, Wang J, Gao M, Zhang J, Yang J, Yang C, Zhang Y, Sun N. Characteristics and mediating Effect of Gut Microbiota with experience of Childhood Maltreatment in Major Depressive Disorder. Front Neurosci. 2022;16:926450.PubMedPubMedCentralCrossRef
52.
Tang Q, Shen D, Dai P, Liu J, Zhang M, Deng K, Li C. Pectin alleviates the pulmonary inflammatory response induced by PM(2.5) from a pig house by modulating intestinal microbiota. Ecotoxicol Environ Saf. 2023;261:115099.PubMedCrossRef
53.
Moon J, Lee AR, Kim H, Jhun J, Lee SY, Choi JW, Jeong Y, Park MS, Ji GE, Cho ML, et al. Faecalibacterium prausnitzii alleviates inflammatory arthritis and regulates IL-17 production, short chain fatty acids, and the intestinal microbial flora in experimental mouse model for rheumatoid arthritis. Arthritis Res Ther. 2023;25(1):130.PubMedPubMedCentralCrossRef
54.
Han X, Song Y, Huang R, Zhu M, Li M, Requena T, Wang H. Anti-inflammatory and gut microbiota modulation potentials of flavonoids extracted from Passiflora foetida Fruits. Foods 2023, 12(15).
55.
Liu S, Yu H, Li P, Wang C, Liu G, Zhang X, Zhang C, Qi M, Ji H. Dietary nano-selenium alleviated intestinal damage of juvenile grass carp (Ctenopharyngodon idella) induced by high-fat diet: insight from intestinal morphology, tight junction, inflammation, anti-oxidization and intestinal microbiota. Anim Nutr. 2022;8(1):235–48.PubMedCrossRef
56.
Han W, Zheng Y, Wang L, An C. Disordered gut microbiota and changes in short-chain fatty acids and inflammatory processes in stress-vulnerable mice. J Neuroimmunol. 2023;383:578172.PubMedCrossRef
57.
Sambataro D, Politi MR, Messina A, Scarpello L, Messina S, Guggino R, Carnaghi C, Caccialanza R, Gebbia V. Relationship of inflammatory parameters and nutritional status in Cancer patients. Anticancer Res. 2023;43(6):2821–9.PubMedCrossRef
58.
van Norren K, Dwarkasing JT, Witkamp RF. The role of hypothalamic inflammation, the hypothalamic-pituitary-adrenal axis and serotonin in the cancer anorexia-cachexia syndrome. Curr Opin Clin Nutr Metab Care. 2017;20(5):396–401.PubMedCrossRef
59.
60.
Zhang Y, Li X, Huang G, Wang H, Chen H, Su Y, Yu K, Zhu W. Propionate stimulates the secretion of satiety hormones and reduces acute appetite in a cecal fistula pig model. Anim Nutr. 2022;10:390–8.PubMedPubMedCentralCrossRef
61.
Chen K, Hu M, Tang M, Gao C, Wang H, Man S, Lu F. Oligosaccharide and short-chain fatty acid: a double-edged sword in obese mice by regulating food intake and fat synthesis. Food Res Int. 2022;159:111619.PubMedCrossRef
62.
Sencio V, Benech N, Robil C, Deruyter L, Heumel S, Machelart A, Sulpice T, Lamaziere A, Grangette C, Briand F, et al. Alteration of the gut microbiota’s composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters. Gut Microbes. 2022;14(1):2100200.PubMedPubMedCentralCrossRef
63.
Maunder K, Molloy E, Jenkins E, Hayden J, Adamis D, McNicholas F. Anorexia nervosa in vivo cytokine production: a systematic review. Psychoneuroendocrinology. 2023;158:106390.PubMedCrossRef
64.
Jennings JH, Rizzi G, Stamatakis AM, Ung RL, Stuber GD. The inhibitory circuit architecture of the lateral hypothalamus orchestrates feeding. Science. 2013;341(6153):1517–21.PubMedPubMedCentralCrossRef
65.
Lebow MA, Chen A. Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders. Mol Psychiatry. 2016;21(4):450–63.PubMedPubMedCentralCrossRef
66.
Wang Y, Kim J, Schmit MB, Cho TS, Fang C, Cai H. A bed nucleus of stria terminalis microcircuit regulating inflammation-associated modulation of feeding. Nat Commun. 2019;10(1):2769.PubMedPubMedCentralCrossRef
67.
Piątkowska-Chmiel I, Krawiec P, Ziętara KJ, Pawłowski P, Samardakiewicz M, Pac-Kożuchowska E, Herbet M. The impact of chronic stress related to COVID-19 on eating behaviors and the risk of obesity in children and adolescents. Nutrients 2023, 16(1).
68.
Siff T, Parajuli P, Razzaque MS, Atfi A. Cancer-mediated muscle Cachexia: etiology and clinical management. Trends Endocrinol Metab. 2021;32(6):382–402.PubMedPubMedCentralCrossRef
69.
Ispoglou T, McCullough D, Windle A, Nair S, Cox N, White H, Burke D, Kanatas A, Prokopidis K. Addressing cancer anorexia-cachexia in older patients: potential therapeutic strategies and molecular pathways. Clin Nutr. 2024;43(2):552–66.PubMedCrossRef
70.
Pastis I, Santos MG, Paruchuri A. Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis. Front Behav Neurosci. 2023;17:1282242.PubMedCrossRef
71.
Tan Y, Xu M, Lin D. Review of research progress on intestinal microbiota based on metabolism and inflammation for depression. Arch Microbiol. 2024;206(4):146.PubMedCrossRef
72.
73.
Bhatt S, Devadoss T, Jha NK, Baidya M, Gupta G, Chellappan DK, Singh SK, Dua K. Targeting inflammation: a potential approach for the treatment of depression. Metab Brain Dis. 2023;38(1):45–59.PubMedCrossRef
74.
Teixeira SA, Moreira JLS, Sousa NRT, Pereira AMC, Rodrigues PN, Santos ASD, Andrade A, Rolim Neto ML, Araújo JEB, Machado SSF, et al. Molecular basis and clinical perspectives of deep brain stimulation for major depressive disorder. J Cereb Blood Flow Metab. 2022;42(4):683–5.PubMedPubMedCentralCrossRef
75.
Jiao H, Fan Y, Gong A, Li T, Fu X, Yan Z. Xiaoyaosan ameliorates CUMS-induced depressive-like and anorexia behaviors in mice via necroptosis related cellular senescence in hypothalamus. J Ethnopharmacol. 2024;318(Pt A):116938.PubMedCrossRef
76.
Colella M, Charitos IA, Ballini A, Cafiero C, Topi S, Palmirotta R, Santacroce L. Microbiota revolution: how gut microbes regulate our lives. World J Gastroenterol. 2023;29(28):4368–83.PubMedPubMedCentralCrossRef
Metadata
Title
Gut microbiota and inflammatory factor characteristics in major depressive disorder patients with anorexia
Authors
Fengtao Guo
Lin Jing
Yunfan Xu
Kun Zhang
Ying Li
Ning Sun
Penghong Liu
Huanhu Zhang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2024
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-024-05778-0

Other articles of this Issue 1/2024

BMC Psychiatry 1/2024 Go to the issue

Research

Exploring adverse events of Vilazodone: evidence from the FAERS database

Research

The patterns, trends and major risk factors of suicide among Indian adolescents – a scoping review

Research

Changes in mental health services in response to the COVID-19 pandemic in high-income countries: a rapid review

Research

Development of stigma scale for women with mental illness in perinatal period, validity and reliability study

Research

Effects of yoga on impulsivity in patients with and without mental disorders: a systematic review

Research

Effects of a single subanesthetic dose of esketamine on postoperative subthreshold depressive symptoms in patients undergoing unilateral modified radical mastectomy: a randomised, controlled, double-blind trial